Meetings

A research team from the Department of Orthopaedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has demonstrated that robotic total hip replacement has a lower reoperation rate than the conventional technique. The study found a 90-day reoperation rate of only 0.6% with robotic procedures as compared to 2.5% with conventional procedures. Robotic procedures thus promise long-term benefits for patients, enabling them to regain mobility and return to normal life.

An upcoming international online forum will bring together leading researchers to explore how engineered biochar can advance carbon capture and sustainable resource recovery, addressing urgent global climate and environmental challenges.

Results of the single-center, phase 2 CAR-PRISM (PRecision Intervention Smoldering Myeloma) clinical trial, the first to investigate Chimeric Antigen Receptor (CAR) T-cell therapy in patients with high-risk smoldering multiple myeloma, showed that all 20 patients were negative for minimal residual disease (MRD) within two months of treatment and remained MRD-negative after a median of 15.3 months of follow-up, and none experienced high-grade side effects, according to results presented at the AACR Annual Meeting 2026, held April 17-22, in San Diego, Calif.

The University of Hong Kong (HKU) announces the launch of the School of Governance and Policy (SGP), a new interdisciplinary hub dedicated to shaping the future of governance and public policy. To mark this milestone, SGP will host its inaugural week from 27 to 29 April 2026, convening global thought leaders, nobel laureate, former heads of state, and leading academics to confront the world’s most urgent regional and transnational challenges.

A phase 1 study aiming to test tolerability of combination therapy with trastuzumab deruxtecan and olaparib in Human Epidermal Growth Factor Receptor 2 (HER2)-expressing malignancies—including ovarian and uterine cancers—found a tolerable dosing schedule with promising activity, according to results reported by Dana-Farber Cancer Institute medical oncologist Dr. Elizabeth Lee at the AACR Annual Meeting 2026, held April 17-22, in San Diego, Calif.

This year’s meeting features more than 80 presentations from Department of Neurology faculty. Here are notable highlights: practical strategies to counter harmful medical myths and misinformation, phase 3 clinical results for a novel epilepsy medication, and the barriers patients with disabilities face while navigating outpatient facilities.

Thawing permafrost buried underneath rivers may be accelerating permafrost degradation faster than previously estimated in these inundated regions, according to new research shared at the 2026 SSA Annual Meeting.